Pyoderma gangrenosum and chronic granulomatous disease treated with adalimumab: Case-based review
Background: Chronic granulomatous disease (CGD) is a rare immunodeficiency disorder that manifested by recurrent severe bacterial and fungal infection. It may be associated with non-infectious inflammatory complications that affect gastrointestinal tract, lung and skin. Pyoderma gangrenosum (PG) is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-04-01
|
| Series: | Egyptian Rheumatologist |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116420300983 |